Loading clinical trials...
Loading clinical trials...
Prospective Clinical Study of Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer
Conditions
Interventions
Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation
Surgery
Locations
1
China
Shanghai 10th People's Hospital
Shanghai, Shanghai Municipality, China
Start Date
January 31, 2019
Primary Completion Date
January 31, 2024
Completion Date
January 31, 2024
Last Updated
February 20, 2019
NCT07485114
NCT06066138
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
Shanghai 10th People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions